FLT3 Inhibitor Highly Active in Newly Diagnosed Acute Myeloid Leukemia
Complete response rate of 86%, median event-free survival approaching 4 years with crenolanib
Source: medpagetoday.com
Eunices Wang News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eunices Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eunices Wang Today - Breaking & Trending Today
How Targeted Drugs Can Vanquish a Virulent Leukemia
A new era of targeted therapy is improving prognoses somewhat and raising hopes that even bigger advancements are on the horizon.
Source: medscape.com
Clinical Insights Concerning Molecular Testing in Patients Diagnosed with Acute Myeloid Leukemia
Eunice S. Wang, MD opens a discussion with other panelists concerning the benefits of germline testing in AML, NCCN guidelines for molecular testing, and how molecular testing in AML is advancing over time.
Source: onclive.com
Astellas to Present Research on FLT3 Mutation-Positive Acute Myeloid Leukemia - from Diagnosis to Relapse - at 2021 American Society of Hematology Annual Meeting
/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced the presentation of new investigational...
Source: prnewswire.com